Net profit of Jenburkt Pharmaceuticals rose 5.83% to Rs 10.16 crore in the quarter ended September 2025 as against Rs 9.60 crore during the previous quarter ended September 2024. Sales rose 10.53% to Rs 45.56 crore in the quarter ended September 2025 as against Rs 41.22 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 45.56 | 41.22 | 11 |
| OPM % | 28.75 | 27.73 | - |
| PBDT | 15.07 | 13.16 | 15 |
| PBT | 14.33 | 12.52 | 14 |
| NP | 10.16 | 9.60 | 6 |